12-31
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- undated
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
Sources
Cite this claim
Plain text
AsOf. "Novartis fiscal year end: 12-31", undated. Claim clm_CF6F00F357D4, https://asof.is/claim/clm_CF6F00F357D4, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448.
APA
AsOf. (n.d.). Novartis fiscal year end: 12-31 (undated) [Record clm_CF6F00F357D4]. Retrieved November 9, 2026, from https://asof.is/claim/clm_CF6F00F357D4 (source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001114448)
BibTeX
@misc{asof_clm_CF6F00F357D4,
author = {AsOf},
title = {Novartis fiscal year end: 12-31},
howpublished = {\url{https://asof.is/claim/clm_CF6F00F357D4}},
note = {Claim clm\_CF6F00F357D4, undated; source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany\&CIK=0001114448},
urldate = {2026-11-09}
}On the record
/claim/clm_CF6F00F357D4.md/v1/claims/clm_CF6F00F357D4submit a correction